TY - JOUR T1 - Cutaneous adverse effects of biologic medications JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 288 LP - 299 DO - 10.3949/ccjm.87a.19119 VL - 87 IS - 5 AU - Selena R. Pasadyn AU - Daniel Knabel AU - Anthony P. Fernandez AU - Christine B. Warren Y1 - 2020/05/01 UR - http://www.ccjm.org/content/87/5/288.abstract N2 - Biologic therapies have become widely used but often cause cutaneous adverse effects. The authors discuss the cutaneous adverse effects of tumor necrosis factor (TNF) alpha inhibitors, epidermal growth factor receptor (EGFR) inhibitors, small-molecule tyrosine kinase inhibitors (TKIs), and cell surface-targeted monoclonal antibodies, including how to manage these reactions and when to refer to a dermatologist. ER -